NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 283 filers reported holding NATERA INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,192,493 | -28.2% | 273,640 | -48.0% | 0.08% | -35.6% |
| Q4 2022 | $21,149,826 | +24.9% | 526,508 | +36.2% | 0.12% | +29.7% |
| Q3 2022 | $16,939,000 | -40.5% | 386,555 | -51.9% | 0.09% | -38.1% |
| Q2 2022 | $28,468,000 | -25.0% | 803,268 | -13.9% | 0.15% | -31.6% |
| Q1 2022 | $37,953,000 | +37.0% | 932,973 | +282.4% | 0.22% | +12.0% |
| Q2 2021 | $27,700,000 | +5.7% | 243,988 | -5.5% | 0.19% | +0.5% |
| Q1 2021 | $26,212,000 | +3495.6% | 258,149 | +3423.7% | 0.19% | +3083.3% |
| Q4 2020 | $729,000 | -85.6% | 7,326 | -92.8% | 0.01% | -89.7% |
| Q2 2020 | $5,068,000 | +379.9% | 101,652 | +187.5% | 0.06% | +93.3% |
| Q1 2020 | $1,056,000 | +48.7% | 35,359 | +67.8% | 0.03% | +114.3% |
| Q4 2019 | $710,000 | – | 21,067 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |